Rankings
▼
Calendar
NAGE (Niagen Bioscience Inc) Stock Financials & Earnings | Market Cap Arena
NAGE
Niagen Bioscience Inc
Mkt Cap
$423M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$129M
Net Income (TTM)
$17M
EPS (TTM)
$0.20
Free Cash Flow (TTM)
$13M
Gross Margin
64.3%
Op. Margin
11.0%
Net Margin
13.4%
FCF Margin
10.2%
P/S Ratio (TTM)
3.3x
P/E Ratio (TTM)
24.4x
YoY Rev Growth
+29.9%
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$23M
$14M
-$2M
Q2 23
$20M
$12M
-$2M
Q3 23
$19M
$12M
-$1M
Q4 23
$21M
$13M
-$168K
Q1 24
$22M
$13M
-$731K
Q2 24
$23M
$14M
-$256K
Q3 24
$26M
$16M
$2M
Q4 24
$29M
$18M
$7M
Q1 25
$30M
$19M
$5M
Q2 25
$31M
$20M
$3M
Q3 25
$34M
$22M
$4M
Q4 25
$34M
$22M
$2M
marketcaparena.com
Revenue Breakdown
NAGE
Niagen Bioscience Inc
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
5.5x
—
Q2 23
5.2x
—
Q3 23
5.1x
—
Q4 23
5.1x
—
Q1 24
5.1x
—
Q2 24
4.9x
—
Q3 24
4.6x
285.1x
Q4 24
4.3x
49.5x
Q1 25
3.9x
30.0x
Q2 25
3.6x
23.9x
Q3 25
3.4x
20.7x
Q4 25
3.3x
24.4x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$3M
$3M
Q2 23
$3M
$3M
Q3 23
$396K
$370K
Q4 23
$649K
$628K
Q1 24
$295K
$254K
Q2 24
-$264K
-$276K
Q3 24
$3M
$3M
Q4 24
$9M
$9M
Q1 25
$8M
$8M
Q2 25
$1M
$1M
Q3 25
$4M
$4M
Q4 25
$624K
$523K
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$91K
Q2 23
$10K
Q3 23
$26K
Q4 23
$21K
Q1 24
$41K
Q2 24
$12K
Q3 24
$41K
Q4 24
$69K
Q1 25
$32K
Q2 25
$135K
Q3 25
$24K
Q4 25
$101K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+30.7%
-1.9%
Q2 23
+21.5%
-2.1%
Q3 23
+14.3%
+2.6%
Q4 23
+1.0%
-4.8%
Q1 24
-1.8%
-6.7%
Q2 24
+11.9%
+1.6%
Q3 24
+31.2%
+16.2%
Q4 24
+37.4%
+3.0%
Q1 25
+37.6%
+12.3%
Q2 25
+36.8%
+21.5%
Q3 25
+32.9%
+24.1%
Q4 25
+16.2%
+44.2%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$1M
5.6%
Q2 23
$1M
6.5%
Q3 23
$1M
5.7%
Q4 23
$1M
4.9%
Q1 24
$984K
4.4%
Q2 24
$1M
5.2%
Q3 24
$735K
2.9%
Q4 24
$752K
2.6%
Q1 25
$1M
3.5%
Q2 25
$1M
4.8%
Q3 25
$0
0.0%
Q4 25
$0
0.0%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
SG&A
Quarter
R&D
G&A
S&M
SG&A
Q1 23
$1M
$6M
$8M
—
Q2 23
$1M
$7M
$6M
—
Q3 23
$1M
$6M
$6M
—
Q4 23
$1M
$5M
$7M
—
Q1 24
$2M
$5M
$7M
—
Q2 24
$1M
$6M
$7M
—
Q3 24
$1M
$6M
$7M
—
Q4 24
$1M
$1M
$9M
—
Q1 25
$1M
$5M
$8M
—
Q2 25
$2M
$7M
$8M
—
Q3 25
$2M
$7M
$9M
—
Q4 25
$2M
—
—
$18M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$23M
$0
$23M
Q2 23
$26M
$0
$26M
Q3 23
$27M
$0
$27M
Q4 23
$27M
$0
$27M
Q1 24
$27M
$0
$27M
Q2 24
$28M
$0
$28M
Q3 24
$32M
$0
$32M
Q4 24
$45M
$0
$45M
Q1 25
$55M
$0
$55M
Q2 25
$60M
$0
$60M
Q3 25
$64M
$0
$64M
Q4 25
$65M
$0
$65M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
75M
+1.2%
Q2 23
75M
+0.2%
Q3 23
75M
+0.1%
Q4 23
75M
+0.1%
Q1 24
75M
+0.2%
Q2 24
76M
+0.4%
Q3 24
78M
+2.9%
Q4 24
82M
+5.0%
Q1 25
83M
+1.9%
Q2 25
86M
+3.6%
Q3 25
87M
+0.4%
Q4 25
84M
-2.5%
marketcaparena.com